BioRestorative Therapies, Inc. (BRTX)
2.14
-0.13
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
2.25
+0.11
(+5.14%)
After-Hours: 20:00
BioRestorative Therapies EPS Diluted (Quarterly) : -2.431 for March 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.431 |
| December 31, 2025 | -7.227 |
| September 30, 2025 | -6.666 |
| June 30, 2025 | -6.078 |
| March 31, 2025 | -12.78 |
| December 31, 2024 | -4.729 |
| September 30, 2024 | -2.688 |
| June 30, 2024 | -9.921 |
| March 31, 2024 | -6.665 |
| December 31, 2023 | 4.982 |
| September 30, 2023 | 7.738 |
| June 30, 2023 | -29.38 |
| March 31, 2023 | -38.59 |
| December 31, 2022 | -23.71 |
| September 30, 2022 | -25.57 |
| June 30, 2022 | -25.70 |
| March 31, 2022 | -27.34 |
| December 31, 2021 | -115.91 |
| September 30, 2021 | -100.00 |
| June 30, 2021 | -102.40 |
| March 31, 2021 | -428.80 |
| December 31, 2020 | -252.80 |
| September 30, 2020 | -41.60 |
| June 30, 2020 | 144.00 |
| March 31, 2020 | -628.80 |
| Date | Value |
|---|---|
| December 31, 2019 | -1593.60 |
| September 30, 2019 | -18799.20 |
| June 30, 2019 | -18994.40 |
| March 31, 2019 | -22765.60 |
| December 31, 2018 | -25933.60 |
| September 30, 2018 | -31580.00 |
| June 30, 2018 | -42400.00 |
| March 31, 2018 | -31200.00 |
| December 31, 2017 | -25600.00 |
| September 30, 2017 | -29600.00 |
| June 30, 2017 | -40800.00 |
| March 31, 2017 | -44800.00 |
| December 31, 2016 | -35014.40 |
| September 30, 2016 | -34400.00 |
| June 30, 2016 | -44800.00 |
| March 31, 2016 | -55200.00 |
| December 31, 2015 | -87200.00 |
| September 30, 2015 | -45600.00 |
| June 30, 2015 | -51200.00 |
| March 31, 2015 | -80000.00 |
| December 31, 2014 | -69952.00 |
| September 30, 2014 | -64000.00 |
| June 30, 2014 | -96000.00 |
| March 31, 2014 | -128000.0 |
| December 31, 2013 | -136816.0 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -0.4557 |
| CareDx, Inc. | 2.071 |
| Natera, Inc. | -0.4674 |
| Exagen, Inc. | -0.1323 |
| Sera Prognostics, Inc. | -0.181 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.154M |
| Revenue (Quarterly) | 0.0232M |
| Total Expenses (Quarterly) | 2.178M |
| Enterprise Value | -0.8314M |
| Gross Profit Margin (Quarterly) | -157.8% |
| Profit Margin (Quarterly) | -9.29K% |
| Earnings Yield | -1.05K% |
| Normalized Earnings Yield | -1220.71 |